COMPOSITE PREPARATION CONTAINING NOVEL 3 (4 (BENZYLOXY)PHENYL)HEX 4 INOIC ACID DERIVATIVE AND ANOTHER ACTIVE INGREDIENT FOR PREVENTING OR TREATING METABOLIC DISEASES
YANG JIN,KIM JIN WOONG,LEE HAN KYU,KIM JAE HYUN,SON CHANG MO,LEE KYU HWAN,CHOI HYUNG HO,KIM DAEHOON,HA TAE YOUNG,RHEE JAEKEOL
申请号：
IN201717017097
公开号：
IN201717017097A
申请日:
2017.05.16
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating metabolic diseases in which a novel 3 (4 (benzyloxy)phenyl)hex 4 inoic acid derivative and at least another active ingredient which is selected from the group consisting of dipeptidyl peptidase 4 (DPPIV) inhibitor based sulfonylurea based thiazolidinedione (TZD) based biguanide based and sodium/glucose cotransporter 2 (SGLT2) inhibitor based drugs may be administered in combination or in the form of a composite preparation. The use of the composition of the present invention can provide a remarkably excellent blood sugar reducing effect in various animal diabetic disease models and the composition of the present invention can be favorably used as a pharmaceutical composition for preventing or treating metabolic diseases such as obesity diabetes type I diabetes type II glucose intolerance symptoms insulin resistance symptoms hyperglycemia hyperlipidemia hypertriglyceridemia hypercholesterolemia dyslipidemia and syndrome X.
